Bioorganic and Medicinal Chemistry Letters p. 2387 - 2392 (1996)
Update date:2022-09-26
Topics:
Wiley, Michael R.
Chirgadze, Nickolay Y.
Clawson, David K.
Craft, Trelia J.
Gifford-Moore, Donetta S.
Jones, Noel D.
Olkowski, Jennifer L.
Weir, Leonard C.
Smith, Gerald F.
The design, synthesis, and enzyme inhibitory profile of D-Phe-Pro-p-Amidinobenzylamine are presented. This compound has inhibitory activity equivalent to D-Phe-Pro-Arg-H, two orders of magnitude more potent than D-Phe-Pro-Agmatine. The results indicate that binding energy provided by the covalent bond of a transition-state analog can be replaced with noncovalent interactions.
View MoreChemsigma International Co.,Ltd.
website:http://www.chemsigma.com
Contact:86-025-58748998
Address:Rm.705, 15th Building,Rd.Xinke II
Contact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
website:https://www.yurisolar.com/en
Contact:86--18092602675
Address:No. 560, East Hangtian Road, Xi'an, China
Wuxi Forest Biological Co.,Ltd
Contact:+86-510-81602300
Address:Room 317,Building D, No.159 middle Chengjiang Road,Jiangyin Wuxi city.
Wuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
Doi:10.1246/bcsj.54.2065
(1981)Doi:10.1016/S0968-0896(98)00152-7
(1998)Doi:10.1016/s0020-1693(97)05682-x
(1997)Doi:10.1055/s-1995-4072
(1995)Doi:10.1016/0040-4020(68)88096-2
(1968)Doi:10.1021/ja9533003
(1996)
